195 related articles for article (PubMed ID: 22147251)
1. Increased expression of VEGF, COX-2, and Ki-67 in Barrett's esophagus: does the length matter?
Zampeli E; Karamanolis G; Morfopoulos G; Xirouchakis E; Kalampoki V; Michopoulos S; Savva S; Tzias V; Zouboulis-Vafiadis I; Kamberoglou D; Ladas SD
Dig Dis Sci; 2012 May; 57(5):1190-6. PubMed ID: 22147251
[TBL] [Abstract][Full Text] [Related]
2. Cyclooxygenase-2 and inflammation mediators have a crucial role in reflux-related esophageal histological changes and Barrett's esophagus.
Taddei A; Fabbroni V; Pini A; Lucarini L; Ringressi MN; Fantappiè O; Bani D; Messerini L; Masini E; Bechi P
Dig Dis Sci; 2014 May; 59(5):949-57. PubMed ID: 24357184
[TBL] [Abstract][Full Text] [Related]
3. [Histochemical diagnosis of short segment Barrett's esophagus].
Fujiyama Y; Ishizuka I; Koyama S
Nihon Rinsho; 2005 Aug; 63(8):1420-6. PubMed ID: 16101233
[TBL] [Abstract][Full Text] [Related]
4. Comparison of COX-2, Ki-67, and BCL-2 expression in normal esophageal mucosa, Barrett's esophagus, dysplasia, and adenocarcinoma with postablation mucosa and implications for ablative therapies.
Lewis CJ; Thrumurthy SG; Pritchard S; Armstrong G; Attwood SE
Surg Endosc; 2011 Aug; 25(8):2564-9. PubMed ID: 21359892
[TBL] [Abstract][Full Text] [Related]
5. Autocrine VEGF signaling promotes proliferation of neoplastic Barrett's epithelial cells through a PLC-dependent pathway.
Zhang Q; Yu C; Peng S; Xu H; Wright E; Zhang X; Huo X; Cheng E; Pham TH; Asanuma K; Hatanpaa KJ; Rezai D; Wang DH; Sarode V; Melton S; Genta RM; Spechler SJ; Souza RF
Gastroenterology; 2014 Feb; 146(2):461-72.e6. PubMed ID: 24120473
[TBL] [Abstract][Full Text] [Related]
6. Acidic Bile Salts Induce Epithelial to Mesenchymal Transition via VEGF Signaling in Non-Neoplastic Barrett's Cells.
Zhang Q; Agoston AT; Pham TH; Zhang W; Zhang X; Huo X; Peng S; Bajpai M; Das K; Odze RD; Spechler SJ; Souza RF
Gastroenterology; 2019 Jan; 156(1):130-144.e10. PubMed ID: 30268789
[TBL] [Abstract][Full Text] [Related]
7. Fatty acid synthase expression in Barrett's esophagus: implications for carcinogenesis.
Ishimura N; Amano Y; Sanchez-Siles AA; Fukuhara H; Takahashi Y; Uno G; Tamagawa Y; Mishima Y; Yuki T; Ishihara S; Kinoshita Y
J Clin Gastroenterol; 2011 Sep; 45(8):665-72. PubMed ID: 21325951
[TBL] [Abstract][Full Text] [Related]
8. Bile acids induce overexpression of homeobox gene CDX-2 and vascular endothelial growth factor (VEGF) in human Barrett's esophageal mucosa and adenocarcinoma cell line.
Burnat G; Rau T; Elshimi E; Hahn EG; Konturek PC
Scand J Gastroenterol; 2007 Dec; 42(12):1460-5. PubMed ID: 17852856
[TBL] [Abstract][Full Text] [Related]
9. Endoscopic features of esophageal adenocarcinoma derived from short-segment versus long-segment Barrett's esophagus.
Yamasaki A; Shimizu T; Kawachi H; Yamamoto N; Yoshimizu S; Horiuchi Y; Ishiyama A; Yoshio T; Hirasawa T; Tsuchida T; Sasaki Y; Fujisaki J
J Gastroenterol Hepatol; 2020 Feb; 35(2):211-217. PubMed ID: 31396997
[TBL] [Abstract][Full Text] [Related]
10. COX-2, CDX2, and CDC2 immunohistochemical assessment for dysplasia-carcinoma progression in Barrett's esophagus.
Villanacci V; Rossi E; Zambelli C; Galletti A; Cestari R; Missale G; Casa DD; Bassotti G
Dig Liver Dis; 2007 Apr; 39(4):305-11. PubMed ID: 17307036
[TBL] [Abstract][Full Text] [Related]
11. Esophageal manometry and ambulatory 24-hour pH monitoring in patients with short and long segment Barrett's esophagus.
Loughney T; Maydonovitch CL; Wong RK
Am J Gastroenterol; 1998 Jun; 93(6):916-9. PubMed ID: 9647018
[TBL] [Abstract][Full Text] [Related]
12. Malignant degeneration of Barrett's esophagus: the role of the Ki-67 proliferation fraction, expression of E-cadherin and p53.
Feith M; Stein HJ; Mueller J; Siewert JR
Dis Esophagus; 2004; 17(4):322-7. PubMed ID: 15569371
[TBL] [Abstract][Full Text] [Related]
13. Immunohistological study of cell cycle-related factors, oncogene expression, and cell proliferation in adenocarcinoma developed in Barrett's esophagus.
Fujii T; Nakagawa S; Hanzawa M; Sueyoshi S; Fujita H; Shirouzu K; Yamana H
Oncol Rep; 2003; 10(2):427-31. PubMed ID: 12579284
[TBL] [Abstract][Full Text] [Related]
14. Angiogenic markers, neovascularization and malignant deformation of Barrett's esophagus.
Wilson KT
Dis Esophagus; 2002; 15(1):16-21. PubMed ID: 12060038
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-alpha, epidermal growth factor receptor, and MiB-1 expression in Barrett's-associated neoplasia: correlation with prognosis.
Yacoub L; Goldman H; Odze RD
Mod Pathol; 1997 Feb; 10(2):105-12. PubMed ID: 9127315
[TBL] [Abstract][Full Text] [Related]
16. [Immunohistochemical expression of the p53 and Ki-67 proteins in Barrett's esophagus in Korea].
Kim CW; Lee BI; Kim BW; Kim JI; Park SH; Kim JK; Han SW; Jung IS; Sun HS; Lee AW; Lee KY
Korean J Gastroenterol; 2005 Sep; 46(3):189-95. PubMed ID: 16179838
[TBL] [Abstract][Full Text] [Related]
17. What is the clinical significance of stromal angiogenesis in Barrett's esophagus?
Moriyama N; Amano Y; Mishima Y; Okita K; Takahashi Y; Yuki T; Ishimura N; Ishihara S; Kinoshita Y
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S210-5. PubMed ID: 19120900
[TBL] [Abstract][Full Text] [Related]
18. Clinical, endoscopic, and functional studies in 408 patients with Barrett's esophagus, compared to 174 cases of intestinal metaplasia of the cardia.
Csendes A; Smok G; Quiroz J; Burdiles P; Rojas J; Castro C; Henríquez A
Am J Gastroenterol; 2002 Mar; 97(3):554-60. PubMed ID: 11922546
[TBL] [Abstract][Full Text] [Related]
19. Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study.
Sikkema M; Kerkhof M; Steyerberg EW; Kusters JG; van Strien PM; Looman CW; van Dekken H; Siersema PD; Kuipers EJ
Am J Gastroenterol; 2009 Nov; 104(11):2673-80. PubMed ID: 19638963
[TBL] [Abstract][Full Text] [Related]
20. Mucin expression and proliferating cell index of esophageal Barrett's adenocarcinoma.
Yamamoto S; Kijima H; Hara T; Chino O; Shimada H; Tanaka M; Inokuchi S; Makuuchi H
Int J Mol Med; 2005 Sep; 16(3):375-80. PubMed ID: 16077942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
